Somerset Therapeutics Private Limited

What Somerset Therapeutics Private Limited does

Somerset Therapeutics Private Limited is a Bengaluru, India-based pharmaceutical contract manufacturer specializing in sterile injectables and ophthalmic preparations, operating as the manufacturing arm of the US-headquartered Veego Group. Its core product portfolio covers large and small volume parenterals (vials 1ml to 100ml and ampoules 1ml to 10ml) across therapeutic categories including NSAIDs, cardiovascular drugs, anti-infectives, analgesics, and iron supplements, alongside a broad ophthalmic range (anti-glaucoma, steroids, anti-infectives, decongestants, and others) produced in three-piece ophthalmic containers from a fully automated plant.

The company runs a cGMP-compliant facility approved by multiple international regulators including the US FDA, ANSM (France), TGA (Australia), Health Canada, Kenya Pharmacy & Poison Board, and Nigeria NAFDAC. Its offering extends beyond manufacturing to formulation development, in-house analytical services, regulatory dossier/CTD compilation, and technology transfer support. The firm has cited 10+ year relationships with multinational pharma clients including Sanofi-Aventis, Novartis, Bayer, and Alcon US, and predominantly serves the US-regulated market through its group entity Somerset Therapeutics LLC.

The business model is B2B contract manufacturing sold via enterprise field sales and relationship-based engagement, with quote-based project pricing rather than disclosed tiered rates. Revenue is generated through professional services engagements spanning formulation development to commercial manufacturing. The company is a private limited subsidiary of Veego Pharma LLC, USA, and was reorganized into its current form in April 2024 after operating historically as Recon Pharma, Recon Limited, and Wintac Limited since its 1987 founding. No venture capital or private equity investment rounds are disclosed in the available sources.

Name

Somerset Therapeutics Private Limited

Legal name

Somerset Therapeutics Private Limited

Website

https://somersetlimited.com

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

251–500 employees

Short description

Somerset Therapeutics Private Limited is an India-based pharmaceutical contract manufacturer specializing in sterile injectables and ophthalmic preparations, serving US-regulated pharmaceutical clients via its parent Veego Group's marketing arm and direct multinational relationships.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Small-Molecule API Commercial Manufacturing (HLAGAHAB)

akta.pro secondary industries

Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA), Pharmaceutical & Medical Glass Packaging (Vials, Ampoules, Syringes) (IMALAEAB), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Sterile pharmaceutical manufacturing
• Injectable contract manufacturing
• Ophthalmic preparations
• Generic pharmaceutical formulations
• Regulatory dossier compilation

Headquarters

HQ city

Bengaluru

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Contract Manufacturing Services: Provides comprehensive outsourcing for sterile pharmaceutical products and ophthalmic solutions. Revenue generated through formulation development to commercial manufacturing services for pharmaceutical customers in the US market. The company predominantly develops and manufactures products for its group entity Somerset Therapeutics LLC, USA.
2. Dossier/Regulatory Services: Regulatory team provides dossier compilation and CTD preparation services for drug registration requirements across global markets

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Somerset Therapeutics Private Limited provides B2B contract manufacturing of sterile pharmaceutical products, specializing in small and large volume parenterals (vials 1ml to 100ml and ampoules 1ml to 10ml) and ophthalmic preparations manufactured in a cGMP-compliant, fully automated facility. The company delivers end-to-end services from formulation development and analytical testing through commercial manufacturing and dossier/CTD regulatory compilation, primarily serving pharmaceutical companies needing sterile manufacturing capacity for the US regulated market.

Product overview

Somerset Therapeutics Private Limited is a pharmaceutical contract manufacturer offering a unified portfolio of sterile pharmaceutical products and services. The core product offerings consist of Injectable Range (large and small volume parenterals including vials and ampoules across multiple therapeutic categories) and Ophthalmic Range (wide range of ophthalmic preparations). These products are complemented by integrated manufacturing services including Contract Manufacturing, Analytical Services, Dossier Compilation, and Formulation Processing—all designed to support pharmaceutical companies seeking custom manufacturing for the US regulated market. The company operates as a cGMP-compliant manufacturing facility serving both its parent company Somerset Therapeutics LLC, USA and external clients.

Differentiator

Problem solved

Functional benefit

Products and services

• Injectable Range Large and small volume parenterals in vials (1ml to 100ml) and ampoules (1ml to 10ml) covering therapeutic categories such as NSAIDs, Calcium Supplements, Anti-emetics, Analgesics, Antimalarials, Anesthetics, Anti-infectives, Antimuscarinics, Diuretics, Cardiovascular drugs, Antihistamines, and Iron supplements. Targeted at pharmaceutical companies seeking USFDA-compliant sterile injectable manufacturing for the US generic market.
• Ophthalmic Range Wide range of ophthalmic preparations manufactured in three-piece ophthalmic containers from a fully automated plant, including Anti-glaucoma, Anti-cholinergic, Artificial tears, NSAIDs, Steroids and combinations, Anti-infectives, Anti-allergics, and Decongestants. Produced for pharmaceutical companies and ophthalmic brands requiring sterile ophthalmic contract manufacturing.
• Contract Manufacturing Services Comprehensive B2B outsourcing for sterile pharmaceutical products and ophthalmic solutions, from formulation development to commercial manufacturing, focused on the US market. Provides custom pharmaceutical contract manufacturing for pharmaceutical companies needing sterile injectable and ophthalmic production capacity.
• Analytical Services Dedicated in-house analytical service department managed by experienced professionals, providing quality control and product development testing to support sterile pharmaceutical manufacturing customers.
• Dossier Compilation Services Regulatory team services providing drug registration requirements including development of Generic Products and Dossiers/CTDs for global markets, supporting customer submissions for sterile pharmaceutical products.
• Formulation Processing Services Core team involved in processing injectables and ophthalmic formulation for the US market, with interdisciplinary project team capabilities supporting customer formulation development and tech transfer.

Quantifiable outcome

• USFDA compliant since 2013 with most recent audit in February 2020 for general GMPs and pre-approvals

Named customers5 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Somerset Therapeutics LLC, USAcoreChannel Partner/ Reseller/ DistributorSomerset Therapeutics Private Limited predominantly develops and manufactures products for its group entity Somerset Therapeutics LLC, USA. Somerset Therapeutics LLC is the marketing arm of VEEGO group, markets and distributes products to all channels of trade including chain drug stores, hospitals, long term care facilities covering the entire US market.
• Sanofi-AventisminorStrategic or Co-development PartnerOver 10 years of relationship with Sanofi-Aventis, a multinational pharmaceutical company. Historical relationship demonstrating experience serving major global pharmaceutical companies.
• NovartisminorStrategic or Co-development PartnerOver 10 years of relationship with Novartis, a multinational pharmaceutical company. Historical relationship demonstrating experience serving major global pharmaceutical companies.
• BayerminorStrategic or Co-development PartnerOver 10 years of relationship with Bayer, a multinational pharmaceutical company. Historical relationship demonstrating experience serving major global pharmaceutical companies.
• Alcon USminorStrategic or Co-development PartnerWell equipped relationship with Alcon US, a major giant in ophthalmics. Company values this relationship as a key partner in the ophthalmic products segment.

Scale indicators4 records

Recent moves13 records

Expansion highlights5 records

Broad incumbents

• Aurobindo Pharma: Aurobindo is a large Indian pharmaceutical manufacturer with growing sterile injectable (Aurolife) capabilities supplying the US generic market. Although much larger and vertically integrated into generics, it competes for the same US sterile injectable contract opportunities as Somerset.
• Baxter International: Baxter is a global incumbent in sterile injectables, IV solutions, and ophthalmic/surgical pharmaceuticals. It is a comparable broad incumbent whose hospital-channel reach overlaps with the US customers Somerset ultimately serves via its group entity.
• Dr. Reddy's Laboratories: Dr. Reddy's is an Indian pharma major with a meaningful sterile injectables portfolio in the US plus global finished-dose CDMO activity. It competes with Somerset for US sterile injectable and ophthalmic contract volumes, and is one of the named adjacency peers in India-based sterile manufacturing.
• Hospira (Pfizer): Hospira, now part of Pfizer, is the global leader in sterile injectable manufacturing and a benchmark for Somerset's product categories (vials, ampoules, ophthalmics). It defines competitive expectations on regulatory compliance and capacity in the same US hospital channel Somerset serves.
• Zydus Lifesciences (Zydus Cadila): Zydus is an Indian pharma major with a meaningful injectables and global generics franchise, including USFDA-approved sterile capacity. It is a comparable adjacency peer targeting the same US generic injectables customer base.
• Lupin: Lupin is an Indian pharmaceutical company with a growing sterile injectable franchise supplying the US market. It competes for the same regulatory-cleared sterile capacity and ophthalmic opportunities as Somerset, although at significantly greater scale.
• Patheon (Thermo Fisher Scientific): Patheon, now part of Thermo Fisher's CDMO business, is a global commercial-scale sterile injectable CDMO. It is a comparable but much larger player offering the same end-to-end formulation-to-commercial-manufacturing services that Somerset provides to US sponsors.

Emerging players

• Alcon: Alcon is the global leader in ophthalmic pharmaceuticals and devices and is itself a customer of Somerset. As a peer, it represents both the demand-side anchor for Somerset's ophthalmic franchise and a competitor to the extent it expands internal or partnered ophthalmic manufacturing capacity.

Direct peers

• Gland Pharma: Gland Pharma is an India-based sterile injectable CDMO serving US generic and innovative customers, including a long relationship with Mylan/Viatris. It is the most directly comparable peer to Somerset, matching the India footprint, US-skewed revenue, sterile focus, and contract-manufacturing model.
• Recipharm: Recipharm is a European-headquartered CDMO with substantial sterile injectable fill-finish capabilities servicing global pharma. It is a comparable CDMO peer on business model, even though it operates a different geographic footprint than Somerset.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/somersetlimited
• Facebookfacebook.com/somersetlimited
• LinkedInlinkedin.com/company/somersetlimited

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Somerset Therapeutics Private Limited